A New Jersey judge has refused to certify a nationwide consumer class action on behalf of more than 30 million people who may have suffered heart damage from taking the drug Propulsid after finding that the case would involve too many individual issues.
The decision in Cartiglia v. Johnson & Johnson is a significant victory for attorneys MaryCatherine Roper and Susan Sharko of Drinker Biddle & Reath because it marks the first ruling on an issue that is currently pending in several courts, including a federal multi-district litigation action.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
